TY - JOUR
T1 - Bismuth salts and neurotoxicity
T2 - A randomised, single-blind and controlled study
AU - Noach, L.A.
AU - Eekhof, J.L.A.
AU - Bour, L.J.
AU - Posthumus Meyjes, F.E.
AU - Tytgat, G.N.J.
AU - Ongerboer de Visser, B.W.
PY - 1995/4
Y1 - 1995/4
N2 - The aim of this work was to investigate whether the nor mal use of colloidal bismuth subcitrate (CBS) and bismuth subnitrate (BSN) exhibits neurotoxic side-effects. A ran domised, single-blind controlled study was carried out in 66 patients with H. pylori associated gastritis. Patients were randomised to receive either amoxicillin (control group) for 4 weeks or BSN for 8 weeks or CBS for 8 weeks. Clinical and neurophysiological tests including elec troneurography (ENG) and spectral electroencephalogra phy (EEG) were performed before and after therapy. No clinically relevant changes were observed with clinical tests as well as with ENG and spectral EEG recordings within each group and between the groups. It was con cluded that the normal use of CBS and BSN does not exhibit clinical neurotoxicity.
AB - The aim of this work was to investigate whether the nor mal use of colloidal bismuth subcitrate (CBS) and bismuth subnitrate (BSN) exhibits neurotoxic side-effects. A ran domised, single-blind controlled study was carried out in 66 patients with H. pylori associated gastritis. Patients were randomised to receive either amoxicillin (control group) for 4 weeks or BSN for 8 weeks or CBS for 8 weeks. Clinical and neurophysiological tests including elec troneurography (ENG) and spectral electroencephalogra phy (EEG) were performed before and after therapy. No clinically relevant changes were observed with clinical tests as well as with ENG and spectral EEG recordings within each group and between the groups. It was con cluded that the normal use of CBS and BSN does not exhibit clinical neurotoxicity.
KW - Bismuth subnitrate
KW - Bismuth toxicity
KW - Colloidal bis muth subcitrate
KW - Electroencephalography
KW - Electroneurography
KW - Neurotoxicity
UR - http://www.scopus.com/inward/record.url?scp=0028916298&partnerID=8YFLogxK
U2 - 10.1177/096032719501400405
DO - 10.1177/096032719501400405
M3 - Article
C2 - 7598995
AN - SCOPUS:0028916298
SN - 0960-3271
VL - 14
SP - 349
EP - 355
JO - Human & Experimental Toxicology
JF - Human & Experimental Toxicology
IS - 4
ER -